MNDY - Hot Stocks: MNDY rose on earnings; FIS drops; FIVE hits 52-week high; GTHX plunges more than 50%

With investors gearing up for key inflation statistics due out the following day, the major U.S. equity averages advanced on Monday. The S&P 500 rose 1.1%, bouncing back from losses recorded through much of last week.

Looking at individual stocks, monday.com ( NASDAQ: MNDY ) posted a double-digit percentage gain after the maker of workflow management software released a Street-beating earnings report. Meanwhile, Five Below ( FIVE ) pushed to a new 52-week high on an upbeat analyst comment.

On the downside, Fidelity National Information Services ( FIS ) slumped after issuing its financial figures and revealing a spinoff plan. At the same time, G1 Therapeutics ( GTHX ) plunged more than 50% to reach a new 52-week low.

Standout Gainer

monday.com ( MNDY ) received significant buying interest after the release of its Q4 financial figures . The stock surged almost 11% on the news.

The company reported a Q4 non-GAAP profit, surprising analysts, who had projected a loss. Revenue jumped 57% to $150M, exceeding expectations.

Looking ahead, MNDY predicted 2023 revenue of $688M to $693M, compared to a consensus of $660M. For Q1, the firm targeted a top-line total of $154M-$156M, surpassing analysts' projection of $150M.

MNDY finished Monday's trading at $145.48, an advance of $14.30 on the day. Looking longer-term, the stock rose from November, when it set a 52-week low of $73.58, into this month, when it recorded its highest close since August.

Even with the earnings-inspired upswing, shares remain off their recent multi-month peak. MNDY has climbed 22% so far in 2023, although it remains 36% lower for the past year.

Standout Decliner

The release of earnings news and the announcement of a spinoff prompted selling in Fidelity National Information Services ( FIS ), with the stock falling by almost 13%.

The financial technology company reported Q4 results that exceeded projections on both the top and bottom lines. However, the firm also provided a weak 2023 forecast , predicting adjusted EPS of $5.70-$6.00. Analysts were looking for a figure of $6.69.

FIS also announced that it planned to spin off its Merchant Solutions business. The unit, which it plans to call Worldpay after it becomes independent, had revenue of $1.18B in Q4.

Dragged down by the forecast, FIS dropped $9.43 to close at $66. With the retreat, the stock reached its lowest finish since late November.

Notable New High

Five Below ( FIVE ) received a boost from a bullish analyst note, pushing the stock to a new 52-week high. Shares rose about 3% on the session.

FIVE closed trading at $207.01, rising $5.37 on the day. During the session, the stock reached an intraday 52-week high of $207.91. The upswing added to recent gains, with the stock climbing 11% over the past month.

Longer-term, shares have been rising since October. FIVE has advanced 50% over the past six months.

Monday's gains came after Roth MKM upgraded the stock to Buy. "FIVE is now seeing revenue volumes come back and new unit expansion ramping up, all in tandem with excess costs being trimmed," analyst David Bellinger wrote.

Notable New Low

Shares of G1 Therapeutics ( GTHX ) cratered after the oncology-focused biotech announced that it had decided to terminate a late-stage trial of a colorectal cancer candidate. The stock plummeted 53% to reach a new 52-week low.

The company ended a Phase 3 study of its trilaciclib product after the data showed that the placebo arm of the trial outperformed results for the patients who received the drug.

The terminated trial sent GTHX to an intraday 52-week low of $3.20. The stock closed at $3.34, a slide of $3.79 on the day.

Looking for more of the day's best- and worst-performing stocks? Turn to Seeking Alpha's On The Move section .

For further details see: